Featured Research

from universities, journals, and other organizations

First Silicon Chip Artificial Retinas Implanted In Blind Patients

Date:
July 3, 2000
Source:
University Of Illinois At Chicago
Summary:
In landmark surgeries at the University of Illinois at Chicago Medical Center on June 28, the first artificial retinas made from silicon chips were implanted in the eyes of two blind patients who have lost almost all their vision because of retinal disease.

In landmark surgeries at the University of Illinois at Chicago Medical Center on June 28, the first artificial retinas made from silicon chips were implanted in the eyes of two blind patients who have lost almost all their vision because of retinal disease. Both patients were released from the hospital the following morning. Preliminary tests determined that no complications had occurred. A third patient received an implant June 29 at Central DuPage Hospital, in Winfield, Illinois.

The surgical team for all three operations consisted of Drs. Alan Chow, president and CEO of Optobionics Corporation of Illinois, the company that invented and developed the artificial retina; Gholam Peyman, professor of ophthalmology and codirector of vitreoretinal surgery at Tulane University Medical Center; and Jose Pulido, professor and head of ophthalmology and visual sciences at the University of Illinois at Chicago.

"We've completed the first part of our journey to the Holy Grail of restoring eyesight to the blind," Pulido said.

The Artificial Silicon Retina (ASRTM) was invented by Chow and his brother Vincent Chow, Optobionics' vice president of engineering. It is a silicon microchip about one-tenth of an inch in diameter and one-thousandth of an inch thick-less than the thickness of a human hair. Preliminary laboratory studies were performed in conjunction with Dr. Neal Peachey and his research group at the Edward Hines, Jr. VA Hospital, in Chicago.

The ASR contains approximately 3,500 microscopic solar cells that convert light into electrical impulses. The purpose of the chip is to replace damaged photoreceptors, the "light-sensing" cells of the eye, which normally convert light into electrical signals within the retina.

Loss of photoreceptor cells occurs in persons with retinitis pigmentosa (RP) and other retinal diseases. All three patients who received the implants have lost almost all their vision from retinitis pigmentosa. The two men and one woman, two of whom use guide dogs, are between 45 and 75 years of age.

The landmark surgeries performed in the two area hospitals were part of a feasibility and safety study approved by the Food and Drug Administration to determine whether the ASR could be safely implanted and tolerated in the human eye.

"In this study, we are evaluating the safety and feasibility of the ASR by placing a small version of the implant in a side portion of the retina," said Alan Chow. "The operations to place the implants in this location were all successfully completed. We hope that if the implants are able to stimulate the retina, patients may develop some degree of vision over the location of the implant within the next month."

The microsurgical procedure starts with three tiny incisions in the white part of the subject's eye, each incision no larger than the diameter of a needle. Through these incisions, the surgeons introduce a miniature cutting and vacuuming device that removes the gel in the middle of the eye and replaces it with saline. They then make a pinpoint opening in the retina through which they inject fluid to lift up a portion of the retina from the back of the eye, creating a small pocket in the "subretinal space" just wide enough to accommodate the ASR. The surgeons then enlarge the pocket opening and insert the implant into the subretinal space. Finally, they reseal the retina over the ASR, introduce air into the middle of the eye to gently push the retina back down over the device, and close the incisions. Over a period of one or two days, the air bubble is reabsorbed and replaced by fluids created within the eye.

"The use of the subretinal space to hold a device that artificially stimulates the retina seems a logical step in replacing the loss of photoreceptor cells of the retina," Peyman explained. "If the implant is tolerated well and is able to successfully stimulate the retina, it may open up new opportunities for restoring sight in patients with the end stages of retinitis pigmentosa."

The UIC College of Medicine is the nation's largest medical school. One out of six Illinois doctors is a graduate of the college, as are 70 percent of the minority physicians practicing in Chicago. The college produces more medical school faculty than all but five schools in the country.

With 25,000 students, the University of Illinois at Chicago is the largest and most diverse university in the Chicago area and is one of only 88 national Research I universities. Located just west of Chicago's Loop, UIC is a vital part of the educational, technological and cultural fabric of the entire metropolitan region.


Story Source:

The above story is based on materials provided by University Of Illinois At Chicago. Note: Materials may be edited for content and length.


Cite This Page:

University Of Illinois At Chicago. "First Silicon Chip Artificial Retinas Implanted In Blind Patients." ScienceDaily. ScienceDaily, 3 July 2000. <www.sciencedaily.com/releases/2000/07/000703101426.htm>.
University Of Illinois At Chicago. (2000, July 3). First Silicon Chip Artificial Retinas Implanted In Blind Patients. ScienceDaily. Retrieved October 20, 2014 from www.sciencedaily.com/releases/2000/07/000703101426.htm
University Of Illinois At Chicago. "First Silicon Chip Artificial Retinas Implanted In Blind Patients." ScienceDaily. www.sciencedaily.com/releases/2000/07/000703101426.htm (accessed October 20, 2014).

Share This



More Health & Medicine News

Monday, October 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

How Nigeria Beat Its Ebola Outbreak

How Nigeria Beat Its Ebola Outbreak

Newsy (Oct. 20, 2014) The World Health Organization has declared Nigeria free of Ebola. Health experts credit a bit of luck and the government's initial response. Video provided by Newsy
Powered by NewsLook.com
Another Study Suggests Viagra Is Good For The Heart

Another Study Suggests Viagra Is Good For The Heart

Newsy (Oct. 20, 2014) An ingredient in erectile-dysfunction medications such as Viagra could improve heart function. Perhaps not surprising, given Viagra's history. Video provided by Newsy
Powered by NewsLook.com
Ebola Worries End for Dozens on U.S. Watch Lists

Ebola Worries End for Dozens on U.S. Watch Lists

Reuters - US Online Video (Oct. 20, 2014) Forty-three people who had contact with Thomas Eric Duncan, the first person diagnosed with Ebola in the U.S., were cleared overnight of twice-daily monitoring after 21 days of showing no symptoms. Rough Cut (no reporter narration). Video provided by Reuters
Powered by NewsLook.com
CDC Calls for New Ebola Safety Guidelines

CDC Calls for New Ebola Safety Guidelines

AP (Oct. 20, 2014) Centers for Disease Control and Prevention Director Dr. Tom Frieden laid out new guidelines for health care workers when dealing with the deadly Ebola virus including new precautions when taking off personal protective equipment. (Oct. 20) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins